Thyroid dysfunction caused by second-generation tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemia.
Kim
Theo D
TD
Clinic for Hematology and Oncology, Charité-Universitätsmedizin Berlin, Berlin, Germany. theo.kim@charite.de
Schwarz
Michaela
M
Nogai
Hendrik
H
Grille
Peggy
P
Westermann
Jörg
J
Plöckinger
Ursula
U
Braun
Doreen
D
Schweizer
Ulrich
U
Arnold
Renate
R
Dörken
Bernd
B
le Coutre
Philipp
P